New drug NHL907 put to the test in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study is testing a new drug, NHL907, in 64 healthy adults aged 18 to 60. The main goal is to see if the drug is safe and how the body handles it. Participants will take multiple doses of the drug or a placebo by mouth. This study does not aim to treat any disease…
Phase: PHASE1 • Sponsor: NeuHyll AUS Pty Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC